Intel-GE joint venture teams with Xavier U. to test health tech

Xavier University

The health-focused joint venture set up by GE Healthcare ($GE) and Intel ($INTC) has teamed with Xavier University to create a permanent testing laboratory. Intel-GE Care Innovations will use the site to test remote patient monitoring and communication technologies.

GE and Intel are both primarily interested in such technologies from a healthcare perspective, but many of the tools are likely to be equally applicable to clinical trials. Having a permanent base from which to test such technologies will give Intel-GE Care Innovations the data with which to counter concerns about the tools' accuracy and reliability. And greater use of the technology would give physicians and researchers a way to monitor patients between site visits.

"The home is a critical component that is often overlooked in population health programs. Most clinicians rely on limited or inaccurate patient data that doesn't encompass the daily life of a patient," Intel-GE Care Innovations CEO Sean Slovenski said in a statement. Intel-GE Care Innovations hopes the testing laboratory and planned summits with alumni of Xavier University will lead to more people attempting to bridge the home-site gap using its technology.

Other initiatives with similar goals are already underway. In June, Intel-GE Care Innovations teamed with OSF Healthcare for a remote monitoring research project. OSF Healthcare's Jump Trading Simulation & Education Center began enrolling patients in the study in November.

- read the release

Suggested Articles

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.

The $58 million financing round represents biopharma industry's growing interest in genomics data.